NCT02273193View on ClinicalTrials.gov

Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes

CompletedOBSERVATIONAL
Enrollment

643

Participants

Timeline

Start Date

October 14, 2014

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions
Gestational Diabetes Mellitus
Trial Locations (1)

89191

Mike O'Callaghan Federal Medical Center, Nellis Air Force Base

All Listed Sponsors
lead

Mike O'Callaghan Military Hospital

FED

NCT02273193 - Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes | Biotech Hunter | Biotech Hunter